ArticlePediatric nephrology (Berlin, Germany)2026
Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure.
Jing Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.